These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 20736512)
1. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice. Hayashi K; Hayashi T; Miyazawa K; Tomoda A J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol. Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002 [TBL] [Abstract][Full Text] [Related]
3. Phenoxazine derivatives inactivate human cytomegalovirus, herpes simplex virus-1, and herpes simplex virus-2 in vitro. Hayashi K; Hayashi T; Tomoda A J Pharmacol Sci; 2008 Mar; 106(3):369-75. PubMed ID: 18319567 [TBL] [Abstract][Full Text] [Related]
4. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro. Bourinbaiar AS; Coleman CF Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588 [TBL] [Abstract][Full Text] [Related]
5. Suppression of proliferation of poliovirus and porcine parvovirus by novel phenoxazines, 2-amino-4,4 alpha-dihydro-4 alpha-7-dimethyl-3H-phenoxazine-3-one and 3-amino-1,4 alpha-dihydro-4 alpha-8-dimethyl-2H-phenoxazine-2-one. Iwata A; Yamaguchi T; Sato K; Yoshitake N; Tomoda A Biol Pharm Bull; 2005 May; 28(5):905-7. PubMed ID: 15863903 [TBL] [Abstract][Full Text] [Related]
6. Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice. Lipipun V; Sasivimolphan P; Yoshida Y; Daikoku T; Sritularak B; Ritthidej G; Likhitwitayawuid K; Pramyothin P; Hattori M; Shiraki K Antiviral Res; 2011 Aug; 91(2):154-60. PubMed ID: 21669230 [TBL] [Abstract][Full Text] [Related]
7. Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo. Dai W; Wu Y; Bi J; Wang S; Li F; Kong W; Barbier J; Cintrat JC; Gao F; Gillet D; Su W; Jiang C Viruses; 2018 Mar; 10(3):. PubMed ID: 29522484 [TBL] [Abstract][Full Text] [Related]
8. In vitro inactivation of herpes simplex virus by a biological response modifier, PSK. Monma Y; Kawana T; Shimizu F Antiviral Res; 1997 Aug; 35(3):131-8. PubMed ID: 9298752 [TBL] [Abstract][Full Text] [Related]
9. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro. Schuhmacher A; Reichling J; Schnitzler P Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations. Bernstein DI; Ireland J; Bourne N Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368 [TBL] [Abstract][Full Text] [Related]
11. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome. Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520 [TBL] [Abstract][Full Text] [Related]
12. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers. Eide K; Moerdyk-Schauwecker M; Stein DA; Bildfell R; Koelle DM; Jin L Antivir Ther; 2010; 15(8):1141-9. PubMed ID: 21149921 [TBL] [Abstract][Full Text] [Related]
13. Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod. Miller RL; Imbertson LM; Reiter MJ; Gerster JF Antiviral Res; 1999 Nov; 44(1):31-42. PubMed ID: 10588331 [TBL] [Abstract][Full Text] [Related]
14. In vivo anti-herpes simplex virus activity of a sulfated derivative of Agaricus brasiliensis mycelial polysaccharide. Cardozo FT; Larsen IV; Carballo EV; Jose G; Stern RA; Brummel RC; Camelini CM; Rossi MJ; Simões CM; Brandt CR Antimicrob Agents Chemother; 2013 Jun; 57(6):2541-9. PubMed ID: 23507287 [TBL] [Abstract][Full Text] [Related]
15. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication. Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682 [TBL] [Abstract][Full Text] [Related]
16. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo. Neyts J; Andrei G; De Clercq E Antimicrob Agents Chemother; 1998 Feb; 42(2):216-22. PubMed ID: 9527762 [TBL] [Abstract][Full Text] [Related]
17. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro. Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431 [TBL] [Abstract][Full Text] [Related]
18. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2. Aboudy Y; Mendelson E; Shalit I; Bessalle R; Fridkin M Int J Pept Protein Res; 1994 Jun; 43(6):573-82. PubMed ID: 7928088 [TBL] [Abstract][Full Text] [Related]
19. Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model. Uhlig N; Donner AK; Gege C; Lange F; Kleymann G; Grunwald T Antiviral Res; 2021 Nov; 195():105190. PubMed ID: 34666109 [TBL] [Abstract][Full Text] [Related]
20. Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. Docherty JJ; Fu MM; Hah JM; Sweet TJ; Faith SA; Booth T Antiviral Res; 2005 Sep; 67(3):155-62. PubMed ID: 16125258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]